CRENESSITY

Serial Number 98976464
819

Registration Progress

Application Filed
Feb 14, 2024
Under Examination
Jan 7, 2025
Approved for Publication
Nov 26, 2024
Published for Opposition
Nov 26, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 1 Granted
Due: Jan 07, 2026 117 days

Trademark Image

CRENESSITY

Basic Information

Serial Number
98976464
Filing Date
February 14, 2024
Published for Opposition
November 26, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
819
Status Date
Aug 25, 2025
Application
Pending
Classes
042 044

Rights Holder

Neurocrine Biosciences, Inc.

03
Address
6027 Edgewood Bend Court
San Diego, CA 92130

Ownership History

Neurocrine Biosciences, Inc.

Original Applicant
03
San Diego, CA

Neurocrine Biosciences, Inc.

Owner at Publication
03
San Diego, CA

Legal Representation

Attorney
Allison Strickland Ricketts

USPTO Deadlines

Next Deadline
117 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
January 07, 2026
Extension Available
Until January 07, 2026

Application History

33 events
Date Code Type Description Documents
Aug 25, 2025 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Aug 25, 2025 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Aug 22, 2025 DPCC D DIVISIONAL PROCESSING COMPLETE Loading...
Aug 22, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Aug 22, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Aug 22, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Aug 22, 2025 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jul 23, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Apr 7, 2025 IUAF S USE AMENDMENT FILED Loading...
Apr 7, 2025 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Apr 7, 2025 ERTD I TEAS REQUEST TO DIVIDE RECEIVED Loading...
Apr 7, 2025 DRRR I DIVISIONAL REQUEST RECEIVED Loading...
Mar 20, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Mar 20, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Mar 20, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 26, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 26, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 25, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Feb 25, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 7, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 26, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 26, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 20, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 4, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 1, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 1, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 1, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 28, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 28, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 28, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 15, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 16, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 14, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Providing medical research information in the field of pharmaceuticals and clinical trials focusing on congenital adrenal hyperplasia
First Use Anywhere: Dec 14, 2024
First Use in Commerce: Dec 14, 2024
Class 044
Providing medical information to patients, medical professionals in the field of congenital adrenal hyperplasia; on-line information services, namely, providing medical information to patients, medical professionals, in the field of congenital adrenal hyperplasia
First Use Anywhere: Dec 14, 2024
First Use in Commerce: Dec 14, 2024

Classification

International Classes
042 044